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Abstract
Although normothermic machine perfusion of donor livers may allow assessment of graft viability prior to transplantation,
there are currently no data on what would be a good parameter of graft viability. To determine whether bile production is a
suitable biomarker that can be used to discriminate viable from non-viable livers we have studied functional performance as
well as biochemical and histological evidence of hepatobiliary injury during ex vivo normothermic machine perfusion of
human donor livers. After a median duration of cold storage of 6.5 h, twelve extended criteria human donor livers that were
declined for transplantation were ex vivo perfused for 6 h at 37uC with an oxygenated solution based on red blood cells and
plasma, using pressure controlled pulsatile perfusion of the hepatic artery and continuous portal perfusion. During
perfusion, two patterns of bile flow were identified: (1) steadily increasing bile production, resulting in a cumulative output
of $30 g after 6 h (high bile output group), and (2) a cumulative bile production ,20 g in 6 h (low bile output group).
Concentrations of transaminases and potassium in the perfusion fluid were significantly higher in the low bile output group,
compared to the high bile output group. Biliary concentrations of bilirubin and bicarbonate were respectively 4 times and 2
times higher in the high bile output group. Livers in the low bile output group displayed more signs of hepatic necrosis and
venous congestion, compared to the high bile output group. In conclusion, bile production could be an easily assessable
biomarker of hepatic viability during ex vivo machine perfusion of human donor livers. It could potentially be used to
identify extended criteria livers that are suitable for transplantation. These ex vivo findings need to be confirmed in a
transplant experiment or a clinical trial.
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Introduction
Donor liver shortage remains a limiting factor in liver transplant
programs in most parts of the world. In an attempt to reduce the
discrepancy between donor liver availability and demand, criteria
for organ acceptance have gradually widened with increasing
acceptance of livers that carry a higher risk of early graft failure or
transmission of an infectious or malignant disease (so called
extended criteria donor (ECD) livers). The types of ECD livers
most frequently considered for transplantation are livers with mild-
moderate steatosis, livers from older donors or donors with a high
body mass index, and livers donated after cardiac death (DCD)
[1], [2], [3]. Although livers from ECD donors are increasingly
considered for transplantation, many of them are still declined. A
recent study in the US has shown that the proportion of donor
livers not used for transplantation is increasing since 2004 [4]. The
proportion of nonuse attributable to DCD increased from 9% in
2004 to 28% in 2010, probably because in many cases the risk of
early graft failure after transplantation is considered to be too high
[4].
The decisions to either accept or decline a potential donor liver
for transplantation is currently based on the interpretation of
donor data, obtained before or during procurement, by the
physician. Parameters such as donor past medical history, last
known laboratory values, findings during liver procurement, and
other procurement variables such as expected ischemia times
primarily determine acceptability of the graft. Once a donor liver
is retrieved and stored in an organ box for transportation
functional assessment is no longer possible until after transplan-
tation. The uncertainty about how much additional damage a liver
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will sustain during the hours of cold storage poses an important
hurdle for accepting many ECD livers.
During the past decade, machine perfusion of donor livers has
received increasing attention as a tool to improve organ
preservation and improve outcome after transplantation [5], [6],
[7], [8], [9]. Several experimental studies have shown superiority
of machine perfusion compared to static cold storage with respect
to reduction of ischemia/reperfusion (IR) injury [10], [11], [12].
Apart from providing better graft protection against IR injury,
machine perfusion provides the possibility of functional assessment
of a liver graft short before implantation in a recipient. Although
machine perfusion can be performed at various temperatures, only
normothermic oxygenated machine perfusion (NMP) may allow a
full functional assessment of an organ prior to transplantation.
During NMP the liver is offered physiological amounts of oxygen
and nutrients supporting a full functional metabolic activity [13].
The possibility of functional assessment of an ECD liver after static
cold storage and transportation would be of great importance in
the judgment of livers that would otherwise be declined for
transplantation based on the current criteria.
Despite the growing amount of literature on the role of machine
perfusion as an alternative and better preservation method
compared to static cold storage, there are no data on what would
be reliable parameters for functional assessment of human donor
livers during NMP. Based on a porcine model of normothermic
liver perfusion, Imber et al. have suggested that bile production is
directly attributed to liver viability and could therefore be used as a
predictive marker of liver function [11]. In addition, bile
production has long been recognized as an important clinical
parameter to predict early graft dysfunction (including primary
non-function and delayed graft function) after liver transplantation
[14]. We, therefore, hypothesized that bile production during
NMP of human donor livers is a suitable and easy to assess
biomarker of hepatic viability that can be used to discriminate a
potentially transplantable from a non-transplantable graft. To test
this hypothesis we have studied functional performance as well as
biochemical and histological signs of hepatobiliary injury during ex
vivo NMP of human donor livers that were declined for
transplantation. Secondary aim of this study was to determine
the minimal duration of NMP needed to discriminate viable and
potentially transplantable livers from non-viable livers.
Materials and Methods
Liver Donors
Between May 2012 and May 2013 twelve human livers that
were declined for transplantation by all three liver transplant
centers in The Netherlands, as well as other centers within the
Eurotransplant region, were included in this study. Of these, ten
were obtained from a DCD donor and two were obtained from
donors after brain death (DBD). The donor risk index (DRI) was
used to assess the chance of graft failure within three months after
transplantation [15]. Livers were retrieved using a standard
surgical technique of in situ cooling and flush-out with ice cold
preservation fluid (University of Wisconsin [UW] or histidine–
tryptophan–ketoglutarate [HTK] solution). The surgical proce-
dure was not started until after a five minute ‘no touch’ period
following declaration of cardiac arrest and circulatory death in
case of a DCD donor. In case of DBD liver procurement the
administration of 25.000 units of heparin was given intravenously
before cross clamping. The same dose of heparin was added to the
preservation solution in case of DCD liver procurement. Livers
were subsequently packed and stored on ice and transported to our
center. In all cases, informed consent to use a donor liver for this
study for this study was provided from the relatives. The study
protocol was approved by the medical ethical committee of the
University Medical Center Groningen and the Nederlandse
Transplantatie Stichting, the competent authority for organ
donation in the Netherlands.
Normothermic Oxygenated Machine Perfusion
Upon arrival at our center, cold preserved livers were prepared
on the back table for normothermic oxygenated machine
perfusion as described previously [13]. NMP was initiated using
a CE marked (European Union certification of safety, health and
environmental requirements) device that enables dual perfusion
via both the hepatic artery and the portal vein in a closed circuit
(Liver Assist Organ Assist, Groningen, Netherlands). Livers were
perfused for 6 h with a perfusion solution based on heparinized
human plasma and red blood cells fortified with nutrients, trace
elements and antibiotics as described previously [13]. Two rotary
pumps provided pulsatile flow to the hepatic artery and a
continuous flow to the portal vein. Two hollow fiber membrane
oxygenators provided oxygenation of the perfusion solution, as
well as removal of CO2. The system was temperature and pressure
controlled, allowing auto-regulation of the blood flow through the
liver. Pressure was limited to a mean of 60 mmHg in the hepatic
artery and 11 mmHg in the portal vein. The temperature was set
to 37uC and a new sterile disposable set of tubing, reservoir and
oxygenators was used for each liver. Before connecting the liver to
the device, the perfusion fluid was primed with the addition of an
8.4% sodium bicarbonate solution to obtain a stable physiological
pH. A summary of the composition of perfusion fluid prior to
initiation of NMP is provided in Table 1.
Assessment of Hepatobiliary Function and Injury
Bile samples were collected from a catheter in the donor
common bile duct and bile production was measured gravimet-
rically at 30 min intervals. Bile production was expressed as g/
30 min. Concentration of bilirubin in bile was determined as a
marker of hepatic secretory function, using standard biochemical
methods. Biliary concentration of bicarbonate and glucose were
determined as markers of biliary epithelial cell (cholangiocyte)
function. For this purpose, bile samples were collected under
mineral oil and analyzed immediately using an ABL800 FLEX
analyzer (Radiometer, Brønhøj, Denmark).
During NMP, samples were taken from the perfusion fluid at
30 min intervals and analyzed immediately for blood gas
parameters (pO2, pCO2, sO2, HCO
32 and pH) and for
biochemical parameters (glucose, calcium, lactate, potassium,
sodium, and hemoglobin) by an ABL800 FLEX analyzer
(Radiometer, Brønhøj, Denmark). Oxygen consumption was
calculated based on the difference between the venous oxygen
content and the arterial oxygen content of the perfusion fluid. The
oxygen content of the perfusion fluid was calculated by adding the
free dissolved oxygen fraction to the Hb-bound oxygen fraction
using the following formula: O2 cont = (pO26K) + (sO26Hb6
c), where pO2 is partial oxygen pressure in kPa, K equals 0,027 for
O2 in water at 37uC, sO2 is the saturation expressed as a fraction,
Hb is the concentration in mmol/L and c equals 91,12 mlO2/
mmol for the oxygen binding capacity of hemoglobin. Oxygen
consumption was expressed in mlO2/min/kilogram liver tissue.
Next to this, hepatic concentration of adenosine-59-triphosphate
(ATP) was used as an indicator of the energy status of the liver
grafts. Liver samples were immediately frozen in liquid nitrogen.
Frozen tissue was cut into 20 mm slices and a total amount of
650 mg was homogenized in 1 mL of SONOP (0.372 g EDTA in
130 mL H2O and NaOH (ph 10.9)+370 mL 96% ethanol) and
Functional Criteria for Liver Machine Perfusion
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sonoficated. Precipitate was removed by centrifugation (13,000 rcf
for 10 min). Supernatant was diluted with SONOP to attain a
protein concentration of 200–300 mg/mL (Pierce BCA Protein
Assay Kit, Thermo Scientific, Rockford, IL) and mixed with
450 mL of 100 mM phosphate buffer (Merck; ph 7.6–8.0). Fifty
microliters of phosphate buffered supernatant was used for ATP
measurement using ATP Biolominescence assay kit CLS II
(Boehringer, Mannheim, Germany) and a luminometer (Victor3
1420 multilabel counter, PerkinElmer). ATP concentrations were
calculated from a calibration curve constructed on the same plate,
corrected for amount of protein, and values were expressed as
mmol/g protein.
In addition, plasma from the perfusion fluid was collected (after
5 min centrifugation at 2700 rpm at 4uC), frozen and stored at 2
80uC for determination of alkaline phosphatase (ALP), gamma-
glutamyl transferase (gamma-GT), alanine aminotransferase
(ALT), lactate dehydrogenase (LDH), total bilirubin, and albumin,
using standard biochemical methods.
Histological Evaluation
Biopsies were obtained from the liver grafts before and after 6 h
of machine perfusion and stored in formalin for histological
evaluation. Paraffin-embedded slides of liver biopsies were
prepared for hematoxylin and eosin (H&E) staining, and assessed
in a semi-quantitative fashion for the presence or absence of
venous congestion or .30% hepatocellular necrosis. All liver and
slides were examined in a blinded fashion by an experienced liver
pathologist (ASHG) using light microscopy.
Statistical Analysis
Continuous variables are presented as medians and interquartile
range (IQR). Categorical variables are presented as number and
percentage. Continuous variables were compared between groups
using the Mann-Whitney U test. Categorical variables were
compared with the Pearson chi-square. Total course of ATP
concentration starting at baseline (before NMP) through 6 h of
NMP was analyzed between the groups by comparing the area
under the curve (AUC, using the trapezium rule). A p-value,0.05
was considered to indicate statistical significance. All statistical
analyses were performed using SPSS software version 16.0 for
Windows (SPSS, Inc., Chicago, IL).
Results
Bile Production as Discriminating Variable during
Machine Perfusion
First aim of this study was to determine whether bile production
is a suitable marker of hepatic viability that can be used during
NMP to discriminate a potentially transplantable from a non-
transplantable graft. Therefore, we determined the evolution of
bile production during 6 h of NMP for all twelve livers. Two
distinct patterns of bile flow could be identified: 1) a steadily
increasing bile production, resulting in a cumulative bile output of
Table 1. Biochemical Composition of Perfusion Fluid Used For Normothermic Machine Perfusion of Donor Livers.
Variable Median IQR Reference values in blood
pH 7.40 7.34–7.45 7.35–7.45
pCO2 (kPa) 4.1 3.5–4.6 4.6–6.0
pO2 (kPa) 71 65–75 9.5–13.5
sO2 (%) 100 99–100 96–99
HCO3- (mmol/L) 19 17–21 21–25
Base Excess (mmol/L) 24.6 26.7–23.5 23 to 3.0
Na+ (mmol/L) 150 145–154 135–145
K+ (mmol/L) 4.4 3.8–5.6 3.5–5.0
Free Ca2+ (mmol/L) 0.67 0.61–0.72 1.15–1.29
Glucose (mmol/L)* 14 13–15 4–9
Lactate (mmol/L)* 6 6–7 0.5–2.2
Hemoglobin (mmol/L)* 4.7 4.6–4.9 8.7–10.6
Albumin (mmol/L) 31 29–33 35–50
Chloride (mmol/L) 97 91–98 97–107
Urea (mmol/L) 3.5 2.9–3.6 2.5–7.5
Phosphate (mmol/L) 1.8 1.5–2.2 0.7–1.5
Magnesium (mmol/L) 0.55 0.51–0.63 0.70–1.00
Alanine-aminotransferase (U/L) 9 8–11 0–45
Aspartate-aminotransferase (U/L) 13 13–17 0–40
Alkaline phosphatase (U/L) 24 23–28 0–120
Gamma-glutamyltransferase (U/L) 9 7–16 0–40
Lactate dehydrogenase (U/L) 101 93–114 0–250
Total bilirubin (mmol/L)* 2 2–3 0–17
* To convert values for glucose to mg/dL, multiply by 18.02. To convert values for lactate to mg/dL, multiply by 9.01. To convert values for hemoglobin to g/dL, multiply
by 1.650. To convert the value for bilirubin to mg/dL, divide by 17.1.
doi:10.1371/journal.pone.0110642.t001
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$30 g during the 6 h of perfusion, and 2) an initially increasing
bile production during the first 2–3 hours, followed by a
diminishing production, resulting in a cumulative bile production
in 6 h ,20 g (Figure 1). Based on this finding of two distinct
profiles of bile production a cutoff value of 20 g cumulative bile
production during 6 h of NMP was chosen to separate high from
low bile output. There were six livers in each group and these two
groups were used for further analyses.
A comparison of donor characteristics between livers with a
high bile output versus livers with a low bile output during ex vivo
machine perfusion is provided in Table 2. There were no
statistically significant differences for any of these variables. Most
livers were declined for transplantation because of a combination
of DCD and age (.60 years) or DCD and high BMI. Two livers
were declined because of macrovesicular steatosis .30% and both
livers were in the low bile output group. It was obvious from this
comparison that one would not have been able to identify livers
with a high versus low bile output before organ procurement based
on conventional donor characteristics alone.
Comparison of Hepatic Function and Injury
We next examined whether the differences in bile production
correlated with other markers of hepatobiliary function and injury
during NMP. First, we compared perfusion characteristics
between the two groups. During NMP the flow in the portal vein
and hepatic artery increased rapidly during the first 30 min and
flows remained stable thereafter for the entire 6 h perfusion period
(Figure 2). There were no significant differences in portal flow and
although median arterial flow was constantly lower in livers with a
low bile output, compared to the high bile output group, this did
not reach statistical significance.
Biochemical markers of hepatobiliary function and injury after
6 h of ex vivo perfusion are presented in Table 3. Most striking
differences were significantly higher concentrations of transami-
nases and a higher potassium level in the perfusion fluid of the low
bile output group, compared to the high bile output group. These
findings are compatible with a higher degree of IR injury and
hepatocellular lysis in the former group. Bicarbonate concentra-
tion in perfusion fluid of livers with high bile output was 26 mmol/
L (22–28 mmol/L), compared to 18 mmol/L (13–29 mmol/L) in
the group of low bile output livers. Although this difference was
not statistically different, it should be noted that about 4-times
more sodium bicarbonate solution (8.4%) had been added during
perfusion in the low bile output group to maintain a physiological
pH. After initiation of machine perfusion, glucose and lactate
concentrations in the perfusion fluid initially increased in all cases.
In the group of livers with high bile output glucose and lactate
levels subsequently decreased rapidly and levels were normal at
6 h of NMP. In contrast, glucose and lactate levels in the low bile
output group did not normalize during machine perfusion.
Albumin levels decreased during all liver perfusions. After 6 h of
NMP, albumin levels in the high bile output group were 23 g/L
(22–24 g/L), compared to 26 (25–29 g/L) in the low bile output
group (Table 3).
At the start of NMP, median pO2 in the perfusate was 71 kPa
(or 533 mmHg) with an interquartile range of 65–75 kPa (or 488–
563 mmHg. After the start of NMP, the pO2 dropped in 4 out of
the 6 livers with low bile output and median pO2 in this group
after 6 hours of NMP was 35 kPa (or 263 mmHg). This was not
significantly different from pO2 values in the high bile output
group (Table 3) and this value is still far above the upper limit of
normal arterial pO2 in vivo (13.5 kPa or 101 mmHg). After 6 hr
of NMP, there was a small, but significant difference in sO2
between the two groups (100% versus 98%), yet median values
never fell below the normal range in vivo (normal values arterial
sO2: 96–99%). In parallel with these changes, total hepatic ATP
content was significantly higher during the course of NMP in the
livers with high bile output, compared to those with low bile
output. At baseline, all livers were ATP depleted with a median in
the high bile output group 7 mmol/g protein compared to 8 mmol/
g in the low bile output group. After 2 h of NMP the ATP had
increased to 50 mmol/g in the high bile output group and to
15 mmol/g in the low bile output group. This difference in ATP
content persisted during the course of NMP and the AUC analysis
Figure 1. Cumulative bile production during ex vivo normothermic machine perfusion of human donor livers. Presented are individual
values for 12 livers that were declined for transplantation. Ex vivo machine perfusion and viability testing was started after a median cold storage of
6.5 hours. Two distinct patterns of bile flow could be identified: 1) a steadily increasing bile production, resulting in a cumulative bile output of $
30 g during the 6 h of perfusion (green lines), and 2) an initially increasing bile production during the first 2–3 hours, followed by a diminishing
production, resulting in a cumulative bile production in 6 h ,20 g (red lines).
doi:10.1371/journal.pone.0110642.g001
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revealed statistical significant difference (p= 0.04; Figure 3). In
addition, pO2 and sO2, oxygen consumption was higher in the
group of livers with low bile output, compared to those with high
bile output, but this did not reach statistical significance.
Biochemical analysis of bile samples during 6 h of NMP
revealed a 4-times higher concentration of bilirubin and a 2-times
higher biliary concentration of bicarbonate in the high bile output
group, compared to the low bile output group (Table 3). These
findings indicate that a better secretory function of hepatocytes
(bilirubin) coincides with that of cholangiocytes (bicarbonate).
Histological Comparison
Finally, we compared histology of liver grafts after 6 h of NMP
between the two groups. In accordance with the observed
differences in biochemical markers of hepatic injury, livers in the
low bile output group displayed more signs of hepatic necrosis and
venous congestion, compared to the high bile output group
(Figure 4 A-D). Venous congestion was present in 5 out of 6 livers
(83%) in the low bile output group and in 2 out of 6 livers (33%) in
the high bile output group (p = 0.08). Necrosis .30% was
observed in 4/6 (66%) of the livers in the low bile output group
and in 2/6 (33%) livers in the high bile output group (p = 0.25).
Despite these differences in hepatic parenchymal damage between
the two groups, there were no major differences in the degree of
biliary damage (Figure 4 E-F).
Minimal Duration of NMP Needed for Viability
Assessment
Secondary aim of this study was to determine the minimal
duration of NMP needed to discriminate viable and potentially
transplantable livers from non-viable livers. For this, we used the
individual data on cumulative bile production as depicted in
Figure 1. It can be deducted from this figure that livers in the low
and high bile output groups can be discriminated from each other
Table 2. Donor Characteristics.
Total group Low Bile Output High Bile Output P-value
(n =12) (n =6) (n=6)
Type of donor 0.12
DCD 10 (83%) 4 (67%) 6 (100%)
DBD 2 (17%) 2 (33%) 0 (0%)
Age (years) 61 (50–64) 55 (48–65) 63 (51–65) 0.47
Gender 0.22
Male 8 (67%) 3 (50%) 1 (17%)
Female 4 (33%) 3 (50%) 5 (83%)
Height (m) 1.77 (1.67–1.80) 1.77 (1.64–1.81) 1.78 (1.71–1.81) 0.69
Weight (kg) 88 (76–98) 90 (85–100) 78 (75–95) 0.20
Reason for rejection 0.25
DCD + age.60 years 5 (41%) 1 (17%) 4 (67%)
DCD + high BMI 3 (25%) 2 (33%) 1 (17%)
DCD + other reason* 2 (17%) 1 (17%) 1 (17%)
Severe steatosis** 2 (17%) 2 (33%) 0 (0%)
Donor Risk Index 2.35 (2.01–2.54) 2.48 (2.23–2.61) 2.20 (1.83–2.42) 0.35
ALT (U/L) *** 38 (24–59) 59 (34–104) 25 (14–49) 0.05
GGT (U/L) *** 90 (39–130) 111 (62–144) 65 (30–130) 0.27
Prothrombin time (sec) 14.0 (12.3–16.3) 15.0 (14.0–16.8) 12.9 (9.1–39.7) 0.20
Preservation Solution 1.00
UW solution 6 (50%) 3 (50%) 3 (50%)
HTK solution 6 (50%) 3 (50%) 3 (50%)
Time between switch-off and cardiac death (min) 24 (15–52) 30 (2–53) 24 (17–53) 0.27
Donor warm ischemia time (min){ 17 (16–20) 19 (9–26) 17 (15–18) 0.31
Total donor warm ischemia (min) { 43 (33–71) 51 (27–72) 43 (34–68) 0.35
Cold ischemia time (min) 389 (458–585) 530 (431–750) 409 (363–473) 0.11
Liver weight (kg) 2.09 (1.60–2.24) 2.17 (1.60–2.31) 2.03 (1.71–2.18) 0.63
* One DCD donor with history of iv drug abuse (low bile output group) and one donor with prolonged s02,30% after withdrawal of life support (high bile output
group).
** defined as macrovesicular steatosis with more than 60% of hepatocytes involved.
*** last known value before procurement.
{Donor warm ischemia times was defined as the time interval between cardiac arrest and start of in situ cold perfusion. Total donor warm ischemia time was defined as
the time interval between switch -off and start of in situ cold perfusion.
Continuous variables are presented as median and interquartile range, categorical variables are presented as numbers and percentage.
Abbreviations used: DCD, donation after cardiac death; DBD, donation after brain death; ALT, alanine aminotransferase; GGT, gamma glutamate transferase; UW,
university of Wisconsin; HTK, Histidine- tryptophan-ketoglutarate.
doi:10.1371/journal.pone.0110642.t002
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as early as 150 min after ex vivo machine perfusion. The
combination of a cumulative bile production of $10 grams at
150 min and a bile production of $4 grams in the preceding hour
identified 100% of the livers that would be considered as a high
bile output liver after 6 h (Table 4). This finding indicates that
after cold storage of a donor liver, a short period of 2.5 hours of ex
vivo assessment during NMP is sufficient to identify a liver that
may been preserved well enough to be transplanted successfully.
Discussion
Machine perfusion of donor livers is receiving increasing
attention as experimental studies have suggested that this method
can provide better protection during storage and transportation,
compared to static cold storage [10], [11], [12]. Especially ECD
livers have been shown to be more susceptible to IR injury,
requiring the introduction of novel and more complex preserva-
tion techniques [7], [16]. Besides the potential benefits of machine
perfusion in providing better protection against preservation
injury, this technique also provides the possibility of viability
testing of a donor organ prior to transplantation. Pretransplant
viability testing may become an important new tool to compensate
for the increasing proportion of ECD livers (i.e. livers from donors
with advanced age, elevated body mass index, diabetes, or livers
from DCD donors), which has resulted in an increasing proportion
of non-use of donor livers during the last decade [4].
The main finding in this study is that bile production can be
used as an easy assessable marker of liver graft viability during ex
vivo NMP. Cumulative bile production of $30 g during 6 h of
NMP was associated with significantly lower release of transam-
inases and potassium into the perfusion fluid and better
hepatobiliary function as reflected by a normalization of glucose
and lactate levels and higher biliary secretion of bilirubin. In
addition, histology of grafts with a high bile output showed less
signs of venous congestion and hepatocellular necrosis, compared
to livers with a low cumulative bile output. The second novel
finding of this study is that the minimal duration of NMP needed
to discriminate viable and potentially transplantable livers from
non-viable livers is 2.5 hours. This relatively short time period
facilitates a timely selection and preparation of a potential
recipient, making this new selection method clinically applicable.
The results of this study open interesting new avenues for the
clinical application of ex vivo viability testing of ECD livers that,
based on conventional criteria, are declined for transplantation.
This method has the potential to have a significant impact on the
number of donor liver available for transplantation. Of the twelve
discarded livers included in this study, 6 (50%) displayed
improving function and normalization of hepatobiliary metabo-
lism. Although all livers were declined for transplantation because
they were considered ECD livers with a too high risk of primary
non-function after transplantation (as indicated by a high DRI),
50% of these may have functioned well after transplantation. All
livers were retrieved from a donor outside our hospital and the
median duration of cold storage prior to initiation of ex vivo
viability testing was 6.5 hours. This time sequence can also be
expected when this technique is introduced in clinical practice.
In an experimental study using pig livers, Imber et al have
previously suggested that bile production is probably the most
important parameter of liver function [11]. The amount of bile
production correlated strongly with the degree of hepatic IR
injury. Our experience with discarded human donor livers is in
line with this experimental study.
The significant higher release of potassium and ALT in low-bile
output livers reflects a higher degree of hepatocellular injury. The
absolute concentrations of ALT measured in the perfusion fluid
may seem relatively high; however, these results cannot be
compared directly with values usually obtained after clinical liver
transplantation. First of all, livers were perfused ex vivo in a closed
circuit and values represent the cumulative release of ALT without
any clearance from the system. Secondly, the perfusion circuit
contained only 2 liters compared to an average of 5 liters of blood
in vivo.
In addition to bile production alone, good liver function was
reflected by a normalization of glucose and lactate levels in the
perfusion fluid, as well as an increasing production of bicarbonate
in the livers with high bile output. The latter was reflected by an
increasing median concentration of bicarbonate in perfusion fluid
from 19 mmol/L at baseline to 26 mmol./L after 6 h of NMP in
the high bile output group. In the low bile output group median
bicarbonate concentration in the perfusion fluid at 6 h was only
18 mmol/L, despite the addition of a 4-times higher amount of
sodium bicarbonate 8.4% during perfusion to maintain a
Figure 2. Changes in portal flow (panel A) and arterial flow
(panel B) during ex vivo normothermic machine perfusion of
human donor livers, using a pressure controlled device. Flow in
the portal vein and hepatic artery increased rapidly during the first
30 min and flows remained stable thereafter for the entire 6 h
perfusion period. There were no significant differences in portal flow
and although median arterial flow was constantly lower in livers with a
low bile output, compared to the high bile output group, this did not
reach statistical significance.
doi:10.1371/journal.pone.0110642.g002
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physiologic pH. These finding are in accordance with a previous
animal study that has indicated that autoregulation of the acid-
base balance is a reflection of a well-functioning liver [17].
During 6 h of NMP albumin levels decreased in all perfusions.
Although levels after 6 h of NMP were slightly (but significantly)
lower in the high bile output group compared to the low bile
output group, this cannot be used as a marker of hepatic synthetic
function because of the overall decline in albumin during all
perfusions.
Interestingly, oxygen consumption appeared to be higher in
livers with low bile production, compared with those with high bile
production. This finding is in agreement with observations made
by Imber et al. during NMP of porcine livers [11]. These
investigators found significantly higher oxygen consumption
during NMP of livers that were severely injured after prolonged
cold preservation, compared to well preserved donor livers. Imber
et al. explained this difference in oxygen consumption by the
respiratory burst and subsequent oxygen debt that occurs in
severely injured post-ischemic livers [11]. In addition, ATP
concentration appeared to be significantly higher in livers with
Table 3. Biochemical Composition of Perfusion Fluid and Bile after 6 hour of Ex Vivo Normothermic Machine Perfusion.
High Bile Output Low Bile Output P- value
(n =6) (n =6)
Blood gas variables
pH 7.36 (7.25–7.40) 7.34 (7.29–7.40) 1.00
pCO2 (kPa)* 6.7 (5.9–7.8) 5.0 (3.4–6.3) 0.08
pO2(kPa)* 64 (54–65) 35 (10–67) 0.42
sO2 (%) 100 (99–100) 98 (94–99) 0.04
HCO3
- (mmol/L) 26 (22–28) 18 (13–29) 0.20
Added HCO3
2 8.4% (mL) 8 (0–20) 25 (4–86) 0.24
Base excess (mmol/L) +0.1 (23.6–+3.6) 26.8 (212.0–24.0) 0.34
Hemoglobin (mmol/L)* 4.2 (3.7–4.3) 4.3 (4.1-4.6) 0.26
Oxygen consumption** (mlO2/min/kilogram liver) 21 (16–22) 60 (27–119) 0.30
Electrolytes and Metabolites
Na+ (mmol/L) 154 (143–155) 142 (139–151) 0.26
K+ (mmol/L) 4 (2–8) 13 (8–18) 0.01
Urea (mmol/L) 14 (11–16) 15 (12–22) 0.63
Albumin (g/L) 23 (22–24) 26 (25–29) 0.01
Glucose (mmol/L)* 10 (8–19) 23 (16–32) 0.07
Lactate (mmol/L)* 2 (1–4) 6 (3–11) 0.03
Injury markers
ALT (U/L) 2795 (1761–3972) 11074 (6144–16050) 0.04
ALP (U/L) 36 (25–44) 154 (82–258) 0.01
GGT (U/L) 35 (20–55) 124 (107–187) 0.06
LDH (U/L) 6227 (5151–6703) 22119 (9584–34558) 0.06
Total bilirubin (mmol/L) 3 (3–3) 5 (3–7) 0.20
Variables measured in bile**
Biliary pH 7.58 (7.56–7.70) 7.37 (7.05–7.71) 0.10
Biliary HCO3
2 (mmol/L) 44 (35–50) 20 (7–41) 0.09
Bilirubin in bile (mmol/L)* 1100 (968–1398) 270 (215–525) 0.02
* To convert values for glucose to mg/dL, multiply by 18.02. To convert values for lactate to mg/dL, multiply by 9.01. To convert values for hemoglobin to g/dL, multiply
by 1.650. To convert the value for bilirubin to mg/dL, divide by 17.1. To convert kPa to mmHg, multiply by 7.5.
** Peak values during 6 h of machine perfusion.
Abbreviations used: ALT, alanine aminotransferase; ALP, alkaline phosphatase; GGT, gamma-glutamate transferase; LDH, lactate dehydrogenase.
doi:10.1371/journal.pone.0110642.t003
Figure 3. Changes in hepatic energy content as reflected by
hepatic ATP content. In contrast to livers with low bile output, livers
in the high bile output group showed a significantly higher hepatic ATP
content during the course of NMP. (AUC p= 0.04).
doi:10.1371/journal.pone.0110642.g003
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Figure 4. Histology of livers after 6 hours of normothermic machine perfusion. In comparison to livers with high bile output, livers in the
low bile output group displayed more signs of hepatic necrosis (panels A and B) and venous congestion (panels C en D). Despite these differences in
hepatic parenchymal damage between the two groups, there were no major differences in the degree of biliary damage (panels E and F).
doi:10.1371/journal.pone.0110642.g004
Table 4. Criteria to Assess Bile Production after 2.5 hours of Normothermic Machine Perfusion.
Liver (Number) Cumulative Bile Output After 2.5 h (g) Bile Output Between 1.5 h and 2.5 h (g)Meets Both Criteria
Low-bile output
1 6.54 2.52 No
2 12.53 3.14 No
3 1.86 0.37 No
4 4.66 2.19 No
5 0.00 0.00 No
6 8.14 2.36 No
High-bile output
7 18.77 7.22 Yes
8 12.93 7.33 Yes
9 14.92 8.50 Yes
10 10.55 5.00 Yes
11 15.72 4.66 Yes
12 25.35 8.85 Yes
Criteria are: 1) Cumulative bile production of $10 grams after 2.5 h and 2) a bile production of $4 grams in the preceding hour (1.5–2.5 h of perfusion).
doi:10.1371/journal.pone.0110642.t004
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high bile production reflecting a higher energy status upon
reperfusion compared to livers with low bile output.
In the current study, we did not add bile salts to the perfusion
fluid. Hepatocellular secretion of bile salts into bile canaliculi is an
important driving force of bile flow [18], [19]. In vivo, bile salts
are reabsorbed from the gut and transported back to the liver
through the enterohepatic circulation. Bile salts are subsequently
secreted again into the bile, causing a choleretic increase in total
bile flow. Obviously, this enterohepatic circulation is interrupted
during ex vivo NMP and this could theoretically lead to bile salt
depletion and a subsequent decline in bile production. However,
experimental studies using pig livers have shown that bile salt
depletion does not occur until after 10 hours of NMP [19]. In the
current study, livers were perfused for 6 hours and we did not
observe a decline in bile output. Therefore, we do not believe the
addition of bile salts is necessary when livers are perfused for less
than 10 hours. In fact, hydrophobic bile salts have been
demonstrated to play a role in bile duct epithelial injury after
liver transplantation and this could be considered an additional
argument not to add bile salts to the perfusion fluid [19], [20],
[21], [22]. On the other hand, due to the strong choleric effect of
bile salts, bile production during ex vivo NMP will be higher when
bile salts are added to the perfusion fluid. This should be kept in
mind when comparing bile output values obtained in different
studies.
Bile production is an energy consuming, multi-step process that
requires an intact network of sinusoidal cells, hepatocytes and
cholangiocytes. Therefore, intuitively, bile production is a strong
and reliable indicator of overall liver quality and viability. In
clinical liver transplantation, poor initial bile production has been
associated with poor outcomes. In one study, graft survival at one
year was only 45% for livers that failed to produce bile in the
operating room [14]. In addition to bile volume, we have shown a
higher biliary secretion of bilirubin in grafts with high bile output,
reflecting a better quality of bile produced by these livers.
Although some studies on kidney and liver machine perfusion
have suggested that a decline in arterial flow in a pressure
controlled system of machine perfusion can be used as a marker of
decreasing graft viability [23], [24], [25], we found stable flows in
both high and low bile output livers. Apparently, change in
perfusion flow is not a reliable parameter of graft viability in
human liver machine perfusion. However, in livers with a low bile
production we did observe a lower arterial flow during the entire
6 h of NMP, compared to the low bile output group, but this did
not reach statistical significance. In general, we do not advise to
use flow values as an indicator of liver damage and viability during
human liver machine perfusion.
A limitation of ex vivo NMP is the inability to assess bile duct
viability. Although the main aim of the current study was to assess
hepatocyte viability, ischemic cholangiopathy, resulting in non-
anastomotic biliary strictures, remains a major complication after
liver transplantation [3]. Unfortunately, reliable markers or other
tools that help predict ischemic cholangiopathy before transplan-
tation are still lacking. Therefore, we cannot rule out that some of
the livers that we considered viable based on ex vivo bile
production may still have developed non-anastomotic biliary
strictures if they had been transplanted. Clearly, there is a need to
develop non-invasive methods that enable assessment of the biliary
epithelium during organ preservation and before implantation. An
attractive option could be the development of molecular imaging
techniques using near-infrared fluorescence that allow a non-
invasive assessment of the biliary epithelium. If such molecular
imaging techniques are combined with visible light cholangioscopy
this could provide a tool for assessment of the biliary tree during
NMP [26], [27].
A second limitation of the study is the relative small number of
liver grafts. Unfortunately human livers do not come available for
research in high numbers. This may have caused a statistical type
II error, explaining the trend towards significance for some
variables as presented in Table 3.
In conclusion, this study suggests that the assessment of bile
production is a discriminative indicator of hepatic function and
injury during ex vivo NMP of human donor livers. It could
potentially be used to identify ECD livers that are declined for
transplantation based on donor risk factors, but that may still be
suitable for transplantation. These findings need to be confirmed
in a clinical trial in which the proposed selection criteria are used
to accept ECD livers that would otherwise have been declined for
transplantation based on an anticipated poor postoperative
function. We are currently preparing such a trial.
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